Understanding the treatment preferences of people with relapsing remitting multiple sclerosis

被引：0
|
作者：
Ford, H. [1 ]
Manzano, A. [2 ]
Eskyte, I. [2 ]
Pavitt, S. [2 ]
Pepper, G. [3 ]
Schmierer, K.
Chataway, J. [4 ]
Potrata, B. [5 ]
Webb, E. [2 ]
Meads, D. [2 ]
Marti, J. [6 ]
Bekker, H. [2 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] Shift Ms, Leeds, W Yorkshire, England
[4] UCL, London, England
[5] Gallup, London, England
[6] Imperial Coll London, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1746
引用
收藏
页码：919 / 920
页数：2
相关论文
共 50 条
  • [31] Treatment with Rituximab in the Acute Phase of Relapsing Remitting Multiple Sclerosis
    Shima, Ayano
    Hamaguchi, Tsuyoshi
    Tada, Yasutake
    Yamada, Masahito
    INTERNAL MEDICINE, 2020, 59 (01) : 121 - 124
  • [32] The cost of teriflunomide in the treatment of relapsing- remitting multiple sclerosis
    Millar, J. Alasdair
    NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1490) : 36 - 41
  • [33] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
    Revel, M
    PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62
  • [34] Oral simvastatin treatment in relapsing-remitting multiple sclerosis
    Vollmer, T
    Key, L
    Durkalski, V
    Tyor, W
    Corboy, J
    Markovic-Plese, S
    Preiningerova, J
    Rizzo, M
    Singh, L
    LANCET, 2004, 363 (9421): : 1607 - 1608
  • [35] Interferons in relapsing remitting multiple sclerosis
    Rudick, RA
    Cookfair, DL
    Griffin, J
    Hauser, S
    Piantadosi, S
    LANCET, 2003, 361 (9371): : 1824 - 1824
  • [36] Daclizumab for relapsing remitting multiple sclerosis
    Liu, Jia
    Wang, Luning
    Zhan, Siyan
    Tan, Jiping
    Xia, Yinyin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [37] SAFETY PROFILE OF DACLIZUMAB FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS
    Kanukula, R.
    Sawant, A.
    Sirumalla, Y.
    Jain, P.
    Belekar, V
    Bhupathi, V. R.
    Sharma, S.
    Likhar, N.
    Dang, A.
    VALUE IN HEALTH, 2016, 19 (07) : A427 - A428
  • [38] Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Jens Ingwersen
    Orhan Aktas
    Hans-Peter Hartung
    Neurotherapeutics, 2016, 13 : 47 - 57
  • [39] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136
  • [40] Pain Intensity and Pain Interference in People With Progressive Multiple Sclerosis Compared With People With Relapsing-Remitting Multiple Sclerosis
    Knowles, Lindsey M.
    Phillips, Kala M.
    Herring, Tracy E.
    Alschuler, Kevin N.
    Jensen, Mark P.
    Turner, Aaron P.
    Ehde, Dawn M.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2021, 102 (10): : 1959 - 1964
12345